Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Lupus
|
June 5, 2004
Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption
P Willeke, B Schlüter, H Schotte, et al.
European Journal of Pain (London, England)
|
February 17, 2012
Cerebral mechanisms of experimental hyperalgesia in fibromyalgia
M Burgmer, B Pfleiderer, C Maihöfner, et al.
Scandinavian Journal of Rheumatology
|
March 10, 2012
Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis
P Willeke, H Becker, B Schlüter, et al.
Der Radiologe
|
July 1, 1994
[Value of direct radiographic enlargement (DIMA) in early detection of rheumatic inflammatory lesions. Comparative evaluation with high resolution conventional imaging technique]
T M Link, M Fiebich, M Gaubitz, et al.
Rheumatology (Oxford, England)
|
March 18, 2004
Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis
H Schotte, B Schlüter, P Willeke, et al.
Zeitschrift Fur Rheumatologie
|
May 1, 1993
[Clinical use of magnification radiography in rheumatologic differential diagnosis]
T M Link, M Gaubitz, H Lenzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2005
Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up
R Reilmann, T Imai, E B Ringelstein, et al.
Annals of the Rheumatic Diseases
|
March 14, 2003
Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome
P Willeke, H Schotte, B Schlüter, et al.
Zeitschrift Fur Rheumatologie
|
January 27, 2019
[Etanercept in routine German clinical practice to treat rheumatoid arthritis patients : A one-year observational study on effectiveness, safety and health economics]
M Gaubitz, R Lippe, K H Göttl, et al.
Annals of the Rheumatic Diseases
|
September 4, 2004
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
H Schotte, B Schlüter, S Drynda, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Lupus
|
June 5, 2004
Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption
P Willeke, B Schlüter, H Schotte, et al.
European Journal of Pain (London, England)
|
February 17, 2012
Cerebral mechanisms of experimental hyperalgesia in fibromyalgia
M Burgmer, B Pfleiderer, C Maihöfner, et al.
Scandinavian Journal of Rheumatology
|
March 10, 2012
Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis
P Willeke, H Becker, B Schlüter, et al.
Der Radiologe
|
July 1, 1994
[Value of direct radiographic enlargement (DIMA) in early detection of rheumatic inflammatory lesions. Comparative evaluation with high resolution conventional imaging technique]
T M Link, M Fiebich, M Gaubitz, et al.
Rheumatology (Oxford, England)
|
March 18, 2004
Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis
H Schotte, B Schlüter, P Willeke, et al.
Zeitschrift Fur Rheumatologie
|
May 1, 1993
[Clinical use of magnification radiography in rheumatologic differential diagnosis]
T M Link, M Gaubitz, H Lenzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2005
Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up
R Reilmann, T Imai, E B Ringelstein, et al.
Annals of the Rheumatic Diseases
|
March 14, 2003
Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome
P Willeke, H Schotte, B Schlüter, et al.
Zeitschrift Fur Rheumatologie
|
January 27, 2019
[Etanercept in routine German clinical practice to treat rheumatoid arthritis patients : A one-year observational study on effectiveness, safety and health economics]
M Gaubitz, R Lippe, K H Göttl, et al.
Annals of the Rheumatic Diseases
|
September 4, 2004
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
H Schotte, B Schlüter, S Drynda, et al.
Page
of 6